Viekira Pak

Chemical Nameombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets
Dosage FormTablet (oral; 150 mg, 100 mg)
Drug ClassAntivirals
SystemBlood
CompanyAbbVie Inc.
Approval Year2014

Indication

  • For the treatment of patients with genotype 1 chronic hepatitis C virus (HCV) infection including those with compensated cirrhosis.
Last updated on 4/19/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?